doi: 10.3390/nu15153375 Pascolini D, Mariotti SP
The direct use of protein neurotrophic factors such as HGF as therapeutic agents has two serious limitations: 1) large size and hydrophilic character precludes BBB permeability
Faster regulatory timelines, large patient pools, and state-backed investment have positioned China as a leader in early-phase and proof-of-concept trials, with a growing share of global clinical assets now originating there
Its unique ability to modulate gene expression and bind copper ions makes it a valuable tool for studies in dermatology, regenerative medicine, and anti-aging research
At Tucson Wellness MD, peptide therapy should be personalized, medically supervised, and based on your symptoms, goals, and overall health profile